We are live on ! Find out more
IBRX icon

ImmunityBio
IBRX

126 hedge funds and large institutions have $381M invested in ImmunityBio in 2021 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 38 increasing their positions, 32 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

145% more capital invested

Capital invested by funds: $155M → $381M (+$226M)

110% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 20

21% more funds holding

Funds holding: 104 → 126 (+22)

19% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 32

6.55% less ownership

Funds ownership: 10.75% → 4.19% (-6.6%)

53% less call options, than puts

Call options by funds: $24M | Put options by funds: $50.7M

Holders
126
Holders Change
+22
Holders Change %
+21.15%
% of All Funds
2.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
42
Increased
38
Reduced
32
Closed
20
Calls
$24M
Puts
$50.7M
Net Calls
-$26.7M
Net Calls Change
-$12.6M

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$43.2M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$13.8M
3
Rafferty Asset Management
Rafferty Asset Management
New York
+$12.1M
4
HP
Harbourvest Partners
Massachusetts
+$9M
5
BlackRock
BlackRock
New York
+$6.49M

Top Sellers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
-$8.63M
2
Group One Trading
Group One Trading
Illinois
-$2.39M
3
N
Nuveen
North Carolina
-$1.5M
4
Bank of New York Mellon
Bank of New York Mellon
New York
-$1.38M
5
Russell Investments Group
Russell Investments Group
United Kingdom
-$1.04M
Name Holding Trade Value Shares
Change 		Change in
Stake
WOC
101
West Oak Capital
California
$36K -$3.11K -120 -7%
OSAM
102
O'Shaughnessy Asset Management
Connecticut
$33K +$32.2K +1,242 +806%
HI
103
Harbour Investments
Wisconsin
$31K +$33.7K +1,300 New
LC
104
Lindbrook Capital
California
$24K – – –
Northwestern Mutual Wealth Management
105
Northwestern Mutual Wealth Management
Wisconsin
$24K – – –
SMG
106
Spectrum Management Group
Indiana
$16K +$17.3K +668 New
SWM
107
Spire Wealth Management
Virginia
$15K +$16K +617 New
SFS
108
Sowell Financial Services
Arkansas
$11K – – –
CFA
109
Carroll Financial Associates
North Carolina
$11K +$13K +500 New
BA
110
Bellwether Advisors
Nebraska
$10K +$12K +462 New
CG
111
Cutler Group
California
$7K -$472K -18,189 -98%
OIA
112
Optimum Investment Advisors
Illinois
$7K -$2.59K -100 -25%
MCM
113
Manchester Capital Management
Vermont
$7K +$7.99K +308 New
PNC Financial Services Group
114
PNC Financial Services Group
Pennsylvania
$6K -$6.48K -250 -50%
AF
115
Advisornet Financial
Minnesota
$6K +$6.48K +250 New
Daiwa Securities Group
116
Daiwa Securities Group
Japan
$5K +$311 +12 +6%
IA
117
IFP Advisors
Florida
$5K +$5.18K +200 New
MAM
118
Meeder Asset Management
Ohio
$4K +$4.77K +184 New
SL
119
Savior LLC
Massachusetts
$2K -$26 -1 -1%
KTC
120
Kistler-Tiffany Companies
Pennsylvania
$2K – – –
Rockefeller Capital Management
121
Rockefeller Capital Management
New York
$2K – – –
Federated Hermes
122
Federated Hermes
Pennsylvania
$2K +$2.38K +92 New
Carson Wealth (CWM LLC)
123
Carson Wealth (CWM LLC)
Nebraska
$1K – – –
AIG
124
American International Group
New York
$436 +$1.24K +48 +0.3%
SWM
125
Sugarloaf Wealth Management
Georgia
$2 +$2.59K +100 New
2 3 4
5
6

IBRX Hedge Fund Activity: Q1 2021 in Review

126 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in ImmunityBio (IBRX) for Q1 2021, worth a combined $381M — up 145% from $155M a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new IBRX positions and 20 closed out — a net gain of 22 holders — while 38 added to existing stakes and 32 trimmed.

The largest buyer was State Street, adding an estimated $43.2M. The largest seller was Invesco, cutting an estimated $8.63M.

  • 126 institutional investors held ImmunityBio (IBRX) as of Q1 2021, up from 104 in Q4 2020.
  • Funds reported $381M of ImmunityBio stock for Q1 2021, up 145% quarter-over-quarter.
  • 42 funds opened new ImmunityBio positions in Q1 2021 and 20 closed out, a net change of +22 holders.
  • The largest ImmunityBio buyer in Q1 2021 was State Street, an estimated $43.2M added.
  • The largest ImmunityBio seller in Q1 2021 was Invesco, an estimated $8.63M sold.

Based on aggregated 13F filings for Q1 2021.